Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling.

Pettersson H, Holmberg L, Axelson M, Norlin M.

FEBS J. 2008 Apr;275(8):1778-89. doi: 10.1111/j.1742-4658.2008.06336.x. Epub 2008 Mar 7.

2.
3.

Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.

Olsson M, Gustafsson O, Skogastierna C, Tolf A, Rietz BD, Morfin R, Rane A, Ekström L.

Prostate. 2007 Sep 15;67(13):1439-46.

PMID:
17639508
4.

Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.

Santen RJ, Demers L, Ohorodnik S, Settlage J, Langecker P, Blanchett D, Goss PE, Wang S.

Steroids. 2007 Jul;72(8):666-71. Epub 2007 May 21.

PMID:
17588628
5.

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.

Macedo LF, Guo Z, Tilghman SL, Sabnis GJ, Qiu Y, Brodie A.

Cancer Res. 2006 Aug 1;66(15):7775-82.

6.

Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5 alpha-reductase inhibitor.

Ishikawa T, Glidewell-Kenney C, Jameson JL.

J Steroid Biochem Mol Biol. 2006 Feb;98(2-3):133-8. Epub 2005 Dec 28.

PMID:
16386416
7.

GREB 1 is a critical regulator of hormone dependent breast cancer growth.

Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME.

Breast Cancer Res Treat. 2005 Jul;92(2):141-9.

8.

The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.

Guerini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Motta M, Poletti A.

Cancer Res. 2005 Jun 15;65(12):5445-53.

9.

Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

Sonne-Hansen K, Lykkesfeldt AE.

J Steroid Biochem Mol Biol. 2005 Jan;93(1):25-34. Epub 2005 Jan 27.

PMID:
15748829
10.

Early onset of puberty and early ovarian failure in CYP7B1 knockout mice.

Omoto Y, Lathe R, Warner M, Gustafsson JA.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2814-9. Epub 2005 Feb 14. Erratum in: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8298.

11.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.

J Clin Oncol. 2005 Jan 20;23(3):619-29. Epub 2004 Nov 15. Review.

PMID:
15545664
12.

The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.

Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ.

Endocrinology. 2005 Jan;146(1):147-55. Epub 2004 Oct 7.

PMID:
15471969
13.

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen.

Johnson MD, Zuo H, Lee KH, Trebley JP, Rae JM, Weatherman RV, Desta Z, Flockhart DA, Skaar TC.

Breast Cancer Res Treat. 2004 May;85(2):151-9.

14.

Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors.

Rae JM, Lippman ME.

Breast Cancer Res Treat. 2004 Jan;83(2):99-107.

15.

An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.

Weihua Z, Lathe R, Warner M, Gustafsson JA.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13589-94. Epub 2002 Oct 7. Erratum in: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8298.

16.
17.

A role for estrogen receptor beta in the regulation of growth of the ventral prostate.

Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M, Gustafsson JA.

Proc Natl Acad Sci U S A. 2001 May 22;98(11):6330-5.

18.

Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha.

Maggiolini M, Donzé O, Jeannin E, Andò S, Picard D.

Cancer Res. 1999 Oct 1;59(19):4864-9.

19.

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.

Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ.

Endocrinology. 1998 Oct;139(10):4164-74.

PMID:
9751496
20.

Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase.

Burak WE Jr, Quinn AL, Farrar WB, Brueggemeier RW.

Breast Cancer Res Treat. 1997 May;44(1):57-64.

PMID:
9164678

Supplemental Content

Support Center